[1] Brown GD,Denning DW,Levitz SM.Tackling human fungal infections[J].Science,2012,336(6082):647.
[2] Komba EV,Mqonda YM.The spectrum of dermatological disorders among primary school children in Dares Salaam[J].BMC Public Health,2010,10:765.
[3] Pai VV,Hanumanthayya K,Tophakhane RS,et al.Clinical study of Tinea capitis in Northern Karnataka:A three-year experience at a single institute[J].Indian Dermatol Online J,2013,4(1):22-26.
[4] 李彩霞,刘维达.我国大陆近年儿童头癣流行情况的回顾分析[J].中国真菌学杂志,2011,6(2):77-81.
[5] Mirmirani P,Tucker LY.Epidemiologic trends in pediatric tinea capitis:a population-based study from Kaiser Permanente Northern California[J].J Am Acad Dermatol,2013,69(6):916-921.
[6] 李美荣,尹颂超,黄怀球,等.广州地区70例儿童头癣病原学分析[J].中国真菌学杂志,2014,9(3):155-158.
[7] 周敬,雷玲,谢平忠,等.湖北赤壁地区296例儿童头癣临床及病原菌分析[J].皮肤病与性病,2014,36(1):1-3.
[8] Kakourou T,Uksal U.Guidelines for the management of tinea capitis in children[J].Pediatr Dermatol,2010,27(3):226-228.
[9] 中华医学会皮肤性病学分会真菌学组.头癣诊疗指南(2008版)[J].中华皮肤科杂志,2009,43(2):76-77.
[10] 罗权,林玲,张锡宝.伊曲康唑在儿童真菌病中的应用[J].国际皮肤性病学杂志,2006,32(5):273-275.
[11] Guinea J.Global trends in the distribution of Candida species causing candidemia[J].Clin Microbiol Infect,2014,20(6):5-10.
[12] 冯晓博,凌波,杨桂梅,等.上海地区1366例浅部念珠菌病致病菌种分析[J].中华皮肤科杂志,2012,45(11):823-825.
[13] Ouederni M,Sanal O,Ikinciogullari A,et,al.Clinical features of candidiasis in patients with inherited interleukin 12 receptor β1 deficiency[J].Clin Infect Dis,2014,58(2):204-213.
[14] 廖万清,王爱平,徐晓光.皮肤念珠菌病诊治[J].中国感染与化疗杂志,2011,11 (2):124-127.
[15] Gulgun M,Balci E,Karaoglu A,et al.Prevalence and risk factors of onychomycosis in primary school children living in rural and urban areas in Central Anatolia of Turkey[J].Indian J Dermatol Venereol Leprol,2013,79(6):777-782.
[16] Young LS,Arbuckle HA,Morelli JG.Onychomycosis in the denver pediatrics population,a retrospective study[J].Pediatr Dermatol,2014,31(1):106-108.
[17] 周敬,雷玲,石玉,等.青少年甲真菌病临床特点及致病菌分析[J].中国麻风皮肤病杂志,2014,30(4):211-213.
[18] Popoola TO,Ojo DA,Alabi RO.Prevalence of dermatophytosis in junior secondary school children in Ogun State,Nigeria[J].Mycoses,2006,49(6):499-503.
[19] 中华医学会皮肤性病学分会真菌学组.甲真菌病诊治指南(2008年版)[J].中华皮肤科杂志,2008,41(12):844-845.
[20] Gupta AK,Paquet M,Simpson FC,Therapies for the treatment of onychomycosis,[J].Clinc Dermatol,2013,31(5):544-554.
[21] Rosen T,Friedlander SF,Kircik L,et al.Onychomycosis:epidemiology,diagnosis,and treatment in a changing landscape[J].J Drugs Dermatol,2015,14(3):223-228.
[22] Kennedy JC,Pottier RH,Pxoss DC.Photodynamic therapy with endogenous protoporphyrin IX:basic principles and present clinical experience[J].Photochem Photobiol B,1990,6(1-2):143-148.
[23] Martinez E,Ameen M,Tejada D,et al.Microsporum spp.Onychomycosis:disease presentation,risk factors and treatment responses in urban population[J].Braz Infect Dis,2014,18(2):181-186.
[24] Gupta AK,Lyons DC.Pityriasis versicolor:an update on pharmacological treatment options[J].Expert opin Pharmacother,2014,15 (12):1707-1713.
[25] 施和建,张国龙,杜旭峰,等.483例儿童花斑癣回顾性分析[J].国际皮肤性病学杂志,2008,34(5):279-281.
[26] 周夕泼,熊琳.马拉色菌相关婴儿皮肤病[J].国际皮肤性病学杂志,2008,34 (1):45-47.